The PLOS One Editors issue this Expression of Concern for this article [1] because of concerns identified about the peer review process. Readers are advised to interpret the article [1] with caution.
The PLOS One Editors also wish to make readers aware that there is substantial overlap between the content of this article and that of another article subsequently published in the Chinese Journal of Hepatology [2].
An internal editorial assessment has established that this constitutes redundant publication. As the first of the two publications, the PLOS One article stands. The Chinese Journal of Hepatology has been informed.
References
- 1. Hu S-L, Zhao F-R, Hu Q, Chen W-X. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS One. 2014;9(7):e101916. pmid:25010534
- 2. Deng HM, Hu SL, Chen WX, Huang Y. Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2016;24(1):62–8. pmid:26983392
Citation: The PLOS One Editors (2026) Expression of concern: Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS One 21(5): e0348620. https://doi.org/10.1371/journal.pone.0348620
Published: May 5, 2026
Copyright: © 2026 The PLOS One Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.